A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients
- Resource Type
- Article
- Source
- In
Cancer / Radiothérapie December 2021 25(8):755-762 - Subject
- Language
- ISSN
- 1278-3218